Microbiome in GI cancer
Neoplasms are one of the main causes of mortality worldwide. Hepatocellular carcinoma (HCC), oesophageal, gastric, and colorectal cancer represent malignancies with major incidence and impact of the gastrointestinal tract. Unfortunately, patients are often diagnosed with advanced stage disease and t...
Main Authors: | F. Franceschi, M. De Siena, G. Gibiino, A. Gasbarrini |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2020-01-01
|
Series: | Microbiota in Health and Disease |
Subjects: | |
Online Access: | https://www.microbiotajournal.com/wp-content/uploads/sites/7/2020/01/e188-Microbiome-in-GI-cancer.pdf |
Similar Items
-
The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
by: Youssef Bouferraa, et al.
Published: (2021-07-01) -
Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
by: Anica Högner, et al.
Published: (2021-02-01) -
The human microbiome, implications for the health-disease process
by: Yacel Pacheco-Pérez, et al.
Published: (2018-11-01) -
Gastrointestinal microbiome, what is behind faecal microbiota transplantation?
by: P. Thomson, et al.
Published: (2021-07-01) -
The Cancer-Immune Set Point in Oesophageal Cancer
by: Robert Power, et al.
Published: (2020-06-01)